Insider acquisitions
Explore purchases, stock awards, gifts, exercises, and conversions. These records cover acquisitions only; sales are not included.
Transaction timeline & trade size
Choose a reporting owner, transaction period, and security. Open any point for the filing.
Oct 28, 2025 – Oct 30, 2025 · Transaction dates · Current page sample
Reported transaction sizes · security units
Catalyst Bancorp, Inc. · Common Stock · Purchase (code P) · Non-derivative · Not reported
Swipe the chart to see the full date range. Exact records are available in the table below.
2 transactions plotted for one security and transaction type. 0 have no reported quantity. A value chart requires a stated currency. Individual reported values remain visible in the table.
50 dated transactions in this page sample · 31 reporting owners.
View timeline as a table
| Transaction date | Company / security | Reporting owners | Acquisition type | Quantity | Price | Reference value | Currency |
|---|---|---|---|---|---|---|---|
| Oct 28, 2025 | CULLEN/FROST BANKERS, INC.Restricted Stock Units | Henson Matthew Bradley (Chief Accounting Officer) | Stock award | 730 | 0 | 0 | Not reported |
| Oct 28, 2025 | CULLEN/FROST BANKERS, INC.Restricted Stock Units | Geddes Dan (GEVP & Chief Financial Officer) | Stock award | 3,956 | 0 | 0 | Not reported |
| Oct 29, 2025 | Primoris Services CorpCommon Stock | Saluja Harpreet (Director) | Stock award | 302 | Not reported | Not reported | Not reported |
| Oct 28, 2025 | CULLEN/FROST BANKERS, INC.Restricted Stock Units | Wilson Kenneth L. (GEVP Chief Wealth Officer) | Stock award | 3,347 | 0 | 0 | Not reported |
| Oct 28, 2025 | CULLEN/FROST BANKERS, INC.Restricted Stock Units | Kasanoff Howard L. (GEVP Chief Credit Officer) | Stock award | 2,739 | 0 | 0 | Not reported |
| Oct 29, 2025 | Primoris Services CorpCommon Stock | Ching Michael E. (Director) | Stock award | 302 | Not reported | Not reported | Not reported |
| Oct 28, 2025 | NXP Semiconductors N.V.Restricted Stock Unit | Betz William (EVP & CFO) | Stock award | 5,213 | 0 | 0 | Not reported |
| Oct 28, 2025 | Catalyst Bancorp, Inc.Common Stock | Kleiser Kirk E. (Director) | Purchase | 4,650 | 13.4099 | 62,356.035 | Not reported |
| Oct 28, 2025 | Catalyst Bancorp, Inc.Common Stock | Kleiser Kirk E. (Director) | Purchase | 100 | 13.4 | 1,340 | Not reported |
| Oct 28, 2025 | CULLEN/FROST BANKERS, INC.Restricted Stock Units | Rhodes Coolidge E JR (Group EVP General Counsel/Sec) | Stock award | 4,260 | 0 | 0 | Not reported |
| Oct 28, 2025 | Janux Therapeutics, Inc.Common Stock | Meyer Andrew Hollman (Chief Business Officer) | Exercise / conversion | 6,666 | 10.59 | 70,592.94 | Not reported |
| Oct 28, 2025 | Janux Therapeutics, Inc.Common Stock | Meyer Andrew Hollman (Chief Business Officer) | Exercise / conversion | 9,999 | 4.21 | 42,095.79 | Not reported |
| Oct 29, 2025 | Primoris Services CorpCommon Stock | Rodriguez Jose Ramon (Director) | Stock award | 302 | Not reported | Not reported | Not reported |
| Oct 28, 2025 | Kiniksa Pharmaceuticals International, plcClass A Ordinary Share | Ragosa Mark (CHIEF FINANCIAL OFFICER) | Exercise / conversion | 100 | 30.93 | 3,093 | Not reported |
| Oct 30, 2025 | Nurix Therapeutics, Inc.Common Stock | van Houte Hans (Chief Financial Officer) | Exercise / conversion | 2,858 | 0 | 0 | Not reported |
| Oct 30, 2025 | Nurix Therapeutics, Inc.Common Stock | van Houte Hans (Chief Financial Officer) | Exercise / conversion | 3,750 | 0 | 0 | Not reported |
| Oct 30, 2025 | Nurix Therapeutics, Inc.Common Stock | van Houte Hans (Chief Financial Officer) | Exercise / conversion | 2,000 | 0 | 0 | Not reported |
| Oct 30, 2025 | Nurix Therapeutics, Inc.Common Stock | van Houte Hans (Chief Financial Officer) | Exercise / conversion | 2,886 | 0 | 0 | Not reported |
| Oct 30, 2025 | Nurix Therapeutics, Inc.Common Stock | Ring Christine (Chief Legal Officer) | Exercise / conversion | 2,858 | 0 | 0 | Not reported |
| Oct 30, 2025 | Nurix Therapeutics, Inc.Common Stock | Ring Christine (Chief Legal Officer) | Exercise / conversion | 3,750 | 0 | 0 | Not reported |
| Oct 30, 2025 | Nurix Therapeutics, Inc.Common Stock | Ring Christine (Chief Legal Officer) | Exercise / conversion | 2,000 | 0 | 0 | Not reported |
| Oct 30, 2025 | Nurix Therapeutics, Inc.Common Stock | Ring Christine (Chief Legal Officer) | Exercise / conversion | 1,924 | 0 | 0 | Not reported |
| Oct 30, 2025 | Nurix Therapeutics, Inc.Common Stock | Hansen Gwenn (Chief Scientific Officer) | Exercise / conversion | 2,858 | 0 | 0 | Not reported |
| Oct 30, 2025 | Nurix Therapeutics, Inc.Common Stock | Hansen Gwenn (Chief Scientific Officer) | Exercise / conversion | 3,750 | 0 | 0 | Not reported |
| Oct 30, 2025 | Nurix Therapeutics, Inc.Common Stock | Hansen Gwenn (Chief Scientific Officer) | Exercise / conversion | 2,000 | 0 | 0 | Not reported |
| Oct 30, 2025 | Nurix Therapeutics, Inc.Common Stock | Hansen Gwenn (Chief Scientific Officer) | Exercise / conversion | 3,207 | 0 | 0 | Not reported |
| Oct 30, 2025 | Bakkt, Inc.Class A Common Stock | ALFRED MICHAEL (Director) | Stock award | 139 | 0 | 0 | Not reported |
| Oct 28, 2025 | NXP Semiconductors N.V.Restricted Stock Unit | Jensen Christopher L (EVP, Chief People Officer) | Stock award | 4,649 | 0 | 0 | Not reported |
| Oct 28, 2025 | Sky Quarry Inc.Common Shares | Sealock David (Former CEO) | Other acquisition | 100,000 | 0.488 | 48,800 | Not reported |
| Oct 28, 2025 | CULLEN/FROST BANKERS, INC.Restricted Stock Units | Severyn Carol Jean (GEVP and Chief Risk Officer) | Stock award | 4,138 | 0 | 0 | Not reported |
| Oct 29, 2025 | Travere Therapeutics, Inc.Common Stock | Dube Eric M (CHIEF EXECUTIVE OFFICER · Director) | Exercise / conversion | 27,128 | 15.46 | 419,398.88 | Not reported |
| Oct 28, 2025 | Travere Therapeutics, Inc.Common Stock | Dube Eric M (CHIEF EXECUTIVE OFFICER · Director) | Exercise / conversion | 92,872 | 15.46 | 1,435,801.12 | Not reported |
| Oct 29, 2025 | CHEMUNG FINANCIAL CORPCOMMON STOCK | STREETER JEFFREY B (Director) | Purchase | 2,184 | 51.9231 | 113,400.0504 | Not reported |
| Oct 30, 2025 | Integer Holdings CorpCommon Stock | Khales Payman (President & CEO · Director) | Purchase | 3,127 | 64.94 | 203,067.38 | Not reported |
| Oct 30, 2025 | ROKU, INCClass A Common Stock | Wood Anthony J. (CEO and Chairman BOD · Director · 10% owner) | Conversion | 18,700 | Not reported | Not reported | Not reported |
| Oct 28, 2025 | ROKU, INCClass A Common Stock | Wood Anthony J. (CEO and Chairman BOD · Director · 10% owner) | Conversion | 2,900 | Not reported | Not reported | Not reported |
| Oct 28, 2025 | CULLEN/FROST BANKERS, INC.Restricted Stock Units | Stead Jimmy (GEVP Chief Consumer Banking) | Stock award | 5,477 | 0 | 0 | Not reported |
| Oct 30, 2025 | IMPINJ INCCommon Stock | DIORIO CHRIS PH.D. (CHIEF EXECUTIVE OFFICER · Director) | Exercise / conversion | 23,500 | 22.4 | 526,400 | Not reported |
| Oct 30, 2025 | Cardlytics, Inc.Common Stock | Gupta Srishti A. (Director) | Exercise / conversion | 6,148 | Not reported | Not reported | Not reported |
| Oct 28, 2025 | CULLEN/FROST BANKERS, INC.Restricted Stock Units | Alonzo Annette M (GEVP Chief HR Officer) | Stock award | 4,260 | 0 | 0 | Not reported |
| Oct 28, 2025 | ARTELO BIOSCIENCES, INC.Convertible Promissory Note | MATSUI CONNIE (Director) | Conversion | Not reported | 110,843 | Not reported | Not reported |
| Oct 28, 2025 | ARTELO BIOSCIENCES, INC.Warrant (right to buy) | MATSUI CONNIE (Director) | Conversion | 70,376 | Not reported | Not reported | Not reported |
| Oct 28, 2025 | ARTELO BIOSCIENCES, INC.Warrant (right to buy) | MATSUI CONNIE (Director) | Conversion | 38,346 | Not reported | Not reported | Not reported |
| Oct 28, 2025 | ARTELO BIOSCIENCES, INC.Convertible Promissory Note | FAVORITO TAMARA A (Director) | Conversion | Not reported | 19,793 | Not reported | Not reported |
| Oct 28, 2025 | ARTELO BIOSCIENCES, INC.Warrant (right to buy) | FAVORITO TAMARA A (Director) | Conversion | 12,566 | Not reported | Not reported | Not reported |
| Oct 28, 2025 | ARTELO BIOSCIENCES, INC.Warrant (right to buy) | FAVORITO TAMARA A (Director) | Conversion | 6,846 | Not reported | Not reported | Not reported |
| Oct 28, 2025 | ARTELO BIOSCIENCES, INC.Convertible Promissory Note | Gorgas Gregory D. (President, CEO, Treasurer, Sec · Director) | Conversion | Not reported | 27,710 | Not reported | Not reported |
| Oct 28, 2025 | ARTELO BIOSCIENCES, INC.Warrant (right to buy) | Gorgas Gregory D. (President, CEO, Treasurer, Sec · Director) | Conversion | 17,952 | Not reported | Not reported | Not reported |
| Oct 28, 2025 | ARTELO BIOSCIENCES, INC.Warrant (right to buy) | Gorgas Gregory D. (President, CEO, Treasurer, Sec · Director) | Conversion | 9,586 | Not reported | Not reported | Not reported |
| Oct 28, 2025 | TaskUs, Inc.Class A Common Stock | Walsh Claudia F (General Counsel) | Exercise / conversion | 16,847 | Not reported | Not reported | Not reported |
Only transactions on this page are shown. Preset date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.
Transaction details
Reporting owners, quantities, prices, and source filings.
| Filed / transacted | Company | Reporting owners | Type / security | Quantity | Price / reference value | Details |
|---|---|---|---|---|---|---|
| Transacted: | CULLEN/FROST BANKERS, INC.No current listing · company listings | Henson Matthew BradleyChief Accounting Officer | Stock awardRestricted Stock UnitsDerivative security · Code A | 730 | 0Value: 0Not reported | View ↗ |
| Transacted: | CULLEN/FROST BANKERS, INC.No current listing · company listings | Geddes DanGEVP & Chief Financial Officer | Stock awardRestricted Stock UnitsDerivative security · Code A | 3,956 | 0Value: 0Not reported | View ↗ |
| Transacted: | Primoris Services CorpPRIM · company listings | Saluja HarpreetDirector | Stock awardCommon StockNon-derivative security · Code A | 302 | Not reported *Value: Not reportedNot reported | View ↗ |
| Transacted: | CULLEN/FROST BANKERS, INC.No current listing · company listings | Wilson Kenneth L.GEVP Chief Wealth Officer | Stock awardRestricted Stock UnitsDerivative security · Code A | 3,347 | 0Value: 0Not reported | View ↗ |
| Transacted: | CULLEN/FROST BANKERS, INC.No current listing · company listings | Kasanoff Howard L.GEVP Chief Credit Officer | Stock awardRestricted Stock UnitsDerivative security · Code A | 2,739 | 0Value: 0Not reported | View ↗ |
| Transacted: | Primoris Services CorpPRIM · company listings | Ching Michael E.Director | Stock awardCommon StockNon-derivative security · Code A | 302 | Not reported *Value: Not reportedNot reported | View ↗ |
| Transacted: | NXP Semiconductors N.V.NXPI · company listings | Betz WilliamEVP & CFO | Stock awardRestricted Stock UnitDerivative security · Code A | 5,213 | 0Value: 0Not reported | View ↗ |
| Transacted: | Catalyst Bancorp, Inc.CLST · company listings | Kleiser Kirk E.Director | PurchaseCommon StockNon-derivative security · Code P | 4,650 | 13.4099Value: 62,356.035Not reported | View ↗ |
| Transacted: | Catalyst Bancorp, Inc.CLST · company listings | Kleiser Kirk E.Director | PurchaseCommon StockNon-derivative security · Code P | 100 | 13.4Value: 1,340Not reported | View ↗ |
| Transacted: | CULLEN/FROST BANKERS, INC.No current listing · company listings | Rhodes Coolidge E JRGroup EVP General Counsel/Sec | Stock awardRestricted Stock UnitsDerivative security · Code A | 4,260 | 0Value: 0Not reported | View ↗ |
| Transacted: | Janux Therapeutics, Inc.JANX · company listings | Meyer Andrew HollmanChief Business Officer | Exercise / conversionCommon StockNon-derivative security · Code M | 6,666 | 10.59Value: 70,592.94Not reported | View ↗ |
| Transacted: | Janux Therapeutics, Inc.JANX · company listings | Meyer Andrew HollmanChief Business Officer | Exercise / conversionCommon StockNon-derivative security · Code M | 9,999 | 4.21Value: 42,095.79Not reported | View ↗ |
| Transacted: | Primoris Services CorpPRIM · company listings | Rodriguez Jose RamonDirector | Stock awardCommon StockNon-derivative security · Code A | 302 | Not reported *Value: Not reportedNot reported | View ↗ |
| Transacted: | Kiniksa Pharmaceuticals International, plcKNSA · company listings | Ragosa MarkCHIEF FINANCIAL OFFICER | Exercise / conversionClass A Ordinary ShareNon-derivative security · Code M | 100 | 30.93Value: 3,093Not reported | View ↗ |
| Transacted: | Nurix Therapeutics, Inc.NRIX · company listings | van Houte HansChief Financial Officer | Exercise / conversionCommon StockNon-derivative security · Code M | 2,858 | 0Value: 0Not reported | View ↗ |
| Transacted: | Nurix Therapeutics, Inc.NRIX · company listings | van Houte HansChief Financial Officer | Exercise / conversionCommon StockNon-derivative security · Code M | 3,750 | 0Value: 0Not reported | View ↗ |
| Transacted: | Nurix Therapeutics, Inc.NRIX · company listings | van Houte HansChief Financial Officer | Exercise / conversionCommon StockNon-derivative security · Code M | 2,000 | 0Value: 0Not reported | View ↗ |
| Transacted: | Nurix Therapeutics, Inc.NRIX · company listings | van Houte HansChief Financial Officer | Exercise / conversionCommon StockNon-derivative security · Code M | 2,886 | 0Value: 0Not reported | View ↗ |
| Transacted: | Nurix Therapeutics, Inc.NRIX · company listings | Ring ChristineChief Legal Officer | Exercise / conversionCommon StockNon-derivative security · Code M | 2,858 | 0Value: 0Not reported | View ↗ |
| Transacted: | Nurix Therapeutics, Inc.NRIX · company listings | Ring ChristineChief Legal Officer | Exercise / conversionCommon StockNon-derivative security · Code M | 3,750 | 0Value: 0Not reported | View ↗ |
| Transacted: | Nurix Therapeutics, Inc.NRIX · company listings | Ring ChristineChief Legal Officer | Exercise / conversionCommon StockNon-derivative security · Code M | 2,000 | 0Value: 0Not reported | View ↗ |
| Transacted: | Nurix Therapeutics, Inc.NRIX · company listings | Ring ChristineChief Legal Officer | Exercise / conversionCommon StockNon-derivative security · Code M | 1,924 | 0Value: 0Not reported | View ↗ |
| Transacted: | Nurix Therapeutics, Inc.NRIX · company listings | Hansen GwennChief Scientific Officer | Exercise / conversionCommon StockNon-derivative security · Code M | 2,858 | 0Value: 0Not reported | View ↗ |
| Transacted: | Nurix Therapeutics, Inc.NRIX · company listings | Hansen GwennChief Scientific Officer | Exercise / conversionCommon StockNon-derivative security · Code M | 3,750 | 0Value: 0Not reported | View ↗ |
| Transacted: | Nurix Therapeutics, Inc.NRIX · company listings | Hansen GwennChief Scientific Officer | Exercise / conversionCommon StockNon-derivative security · Code M | 2,000 | 0Value: 0Not reported | View ↗ |
| Transacted: | Nurix Therapeutics, Inc.NRIX · company listings | Hansen GwennChief Scientific Officer | Exercise / conversionCommon StockNon-derivative security · Code M | 3,207 | 0Value: 0Not reported | View ↗ |
| Transacted: | Bakkt, Inc.BKKT · company listings | ALFRED MICHAELDirector | Stock awardClass A Common StockNon-derivative security · Code A | 139 | 0Value: 0Not reported | View ↗ |
| Transacted: | NXP Semiconductors N.V.NXPI · company listings | Jensen Christopher LEVP, Chief People Officer | Stock awardRestricted Stock UnitDerivative security · Code A | 4,649 | 0Value: 0Not reported | View ↗ |
| Transacted: | Sky Quarry Inc.SKYQ · company listings | Sealock DavidFormer CEO | Other acquisitionCommon SharesNon-derivative security · Code S | 100,000 | 0.488Value: 48,800Not reported | View ↗ |
| Transacted: | CULLEN/FROST BANKERS, INC.No current listing · company listings | Severyn Carol JeanGEVP and Chief Risk Officer | Stock awardRestricted Stock UnitsDerivative security · Code A | 4,138 | 0Value: 0Not reported | View ↗ |
| Transacted: | Travere Therapeutics, Inc.TVTX · company listings | Dube Eric MCHIEF EXECUTIVE OFFICER · Director | Exercise / conversionCommon StockNon-derivative security · Code M | 27,128 | 15.46Value: 419,398.88Not reported | View ↗ |
| Transacted: | Travere Therapeutics, Inc.TVTX · company listings | Dube Eric MCHIEF EXECUTIVE OFFICER · Director | Exercise / conversionCommon StockNon-derivative security · Code M | 92,872 | 15.46Value: 1,435,801.12Not reported | View ↗ |
| Transacted: | CHEMUNG FINANCIAL CORPCHMG · company listings | STREETER JEFFREY BDirector | PurchaseCOMMON STOCKNon-derivative security · Code P | 2,184 | 51.9231Value: 113,400.0504Not reported | View ↗ |
| Transacted: | Integer Holdings CorpITGR · company listings | Khales PaymanPresident & CEO · Director | PurchaseCommon StockNon-derivative security · Code P | 3,127 | 64.94 *Value: 203,067.38Not reported | View ↗ |
| Transacted: | ROKU, INCROKU · company listings | Wood Anthony J.CEO and Chairman BOD · Director · 10% owner | ConversionClass A Common StockNon-derivative security · Code C | 18,700 | Not reported *Value: Not reportedNot reported | View ↗ |
| Transacted: | ROKU, INCROKU · company listings | Wood Anthony J.CEO and Chairman BOD · Director · 10% owner | ConversionClass A Common StockNon-derivative security · Code C | 2,900 | Not reported *Value: Not reportedNot reported | View ↗ |
| Transacted: | CULLEN/FROST BANKERS, INC.No current listing · company listings | Stead JimmyGEVP Chief Consumer Banking | Stock awardRestricted Stock UnitsDerivative security · Code A | 5,477 | 0Value: 0Not reported | View ↗ |
| Transacted: | IMPINJ INCPI · company listings | DIORIO CHRIS PH.D.CHIEF EXECUTIVE OFFICER · Director | Exercise / conversionCommon StockNon-derivative security · Code M | 23,500 | 22.4Value: 526,400Not reported | View ↗ |
| Transacted: | Cardlytics, Inc.CDLX · company listings | Gupta Srishti A.Director | Exercise / conversionCommon StockNon-derivative security · Code M | 6,148 | Not reported *Value: Not reportedNot reported | View ↗ |
| Transacted: | CULLEN/FROST BANKERS, INC.No current listing · company listings | Alonzo Annette MGEVP Chief HR Officer | Stock awardRestricted Stock UnitsDerivative security · Code A | 4,260 | 0Value: 0Not reported | View ↗ |
| Transacted: | ARTELO BIOSCIENCES, INC.ARTL · company listings | MATSUI CONNIEDirector | ConversionConvertible Promissory NoteDerivative security · Code C | Not reported | 110,843Value: Not reportedNot reported | View ↗ |
| Transacted: | ARTELO BIOSCIENCES, INC.ARTL · company listings | MATSUI CONNIEDirector | ConversionWarrant (right to buy)Derivative security · Code C | 70,376 | Not reported *Value: Not reportedNot reported | View ↗ |
| Transacted: | ARTELO BIOSCIENCES, INC.ARTL · company listings | MATSUI CONNIEDirector | ConversionWarrant (right to buy)Derivative security · Code C | 38,346 | Not reported *Value: Not reportedNot reported | View ↗ |
| Transacted: | ARTELO BIOSCIENCES, INC.ARTL · company listings | FAVORITO TAMARA ADirector | ConversionConvertible Promissory NoteDerivative security · Code C | Not reported | 19,793Value: Not reportedNot reported | View ↗ |
| Transacted: | ARTELO BIOSCIENCES, INC.ARTL · company listings | FAVORITO TAMARA ADirector | ConversionWarrant (right to buy)Derivative security · Code C | 12,566 | Not reported *Value: Not reportedNot reported | View ↗ |
| Transacted: | ARTELO BIOSCIENCES, INC.ARTL · company listings | FAVORITO TAMARA ADirector | ConversionWarrant (right to buy)Derivative security · Code C | 6,846 | Not reported *Value: Not reportedNot reported | View ↗ |
| Transacted: | ARTELO BIOSCIENCES, INC.ARTL · company listings | Gorgas Gregory D.President, CEO, Treasurer, Sec · Director | ConversionConvertible Promissory NoteDerivative security · Code C | Not reported | 27,710Value: Not reportedNot reported | View ↗ |
| Transacted: | ARTELO BIOSCIENCES, INC.ARTL · company listings | Gorgas Gregory D.President, CEO, Treasurer, Sec · Director | ConversionWarrant (right to buy)Derivative security · Code C | 17,952 | Not reported *Value: Not reportedNot reported | View ↗ |
| Transacted: | ARTELO BIOSCIENCES, INC.ARTL · company listings | Gorgas Gregory D.President, CEO, Treasurer, Sec · Director | ConversionWarrant (right to buy)Derivative security · Code C | 9,586 | Not reported *Value: Not reportedNot reported | View ↗ |
| Transacted: | TaskUs, Inc.TASK · company listings | Walsh Claudia FGeneral Counsel | Exercise / conversionClass A Common StockNon-derivative security · Code M | 16,847 | Not reported *Value: Not reportedNot reported | View ↗ |
50 transactions on this page. Filing date, newest first.
Filters use the date a filing was submitted, not the date of the transaction. Coverage is incomplete while historical records are being loaded. How we organize the data →